1.Ada, G.Strategies for exploiting the immune system in the design of vaccines. Molecular Immunology, 1991, 28, 225–30.
2.Alonso, M. J., Cohen, S., Park, T. G., et al. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharmaceutical Research, 1993, 10, 945–53.
3.Alving, C. R.Delivery of liposome-encapsulated drugs to macrophages. Pharmacological Therapy, 1983, 22, 407–24.
4.Alving, C. R., Richards, R. L., & Moss, J.Effectiveness of liposomes as potential carriers for vaccines; application to cholera toxin and human malaria sporozoite antigen. Vaccine, 1986, 4, 166–72.
5.Cohen, S., Baño, M. C., Chow, M., et al. Alginate-lipid interactions can render changes in bilayer lipid permeability. Biochimica et Biophysica Acta, 1991, 1063, 95–102.
6.Cohen, S., Bernstein, H., Hewes, C., et al. The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes. Proceedings of the National Academy of Sciences of the United States of America, 1991, 88, 10440–44.
7.Cohen, S., Cochrane, A., Nardin, E., et al. Poly(lactic/glycolic acid) microspheres- immunization vehicles for synthetic peptide vaccines. Polymeric Materials Science and Engineering, 1992, 66, 91–92.
8.Cohen, S., Yoshioka, T., Lucarelli, M., et al. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharmaceutical Research, 1991, 8, 713–20.
9.Davis, D., & Gregoriadis, G.Liposomes as adjuvants with immunopurified tetanus toxoid: Influence of liposomal characteristics. Immunology, 1987, 61, 229–34.
10.Eldridge, J. H., Gilley, R. M., Staas, J. K., et al. Biodegradable microspheres: Vaccine delivery system for oral administration. Current Topics in Microbiology and Immunology, 1989, 146, 59–66.
11.Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target Peyer's patches. Journal of Controlled Release, 1990, 11, 205–14.
12.Eldridge, J. H., Meulbroek, J. A., Staas, J. K., et al. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Advanced Experiments in Medicine and Biology, 1989, 251, 192–202.
13.Eldridge, J. H., Staas, J. K., Meulbroek, J. A., et al. Biodegradable and biocompatible poly (D, L-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhance the level of toxin-neutralizing antibodies. Infection and Immunity, 1991, 59, 2978–86.
14.Esparza, I., & Kissel, T.Parameters affecting the immunogenicity of microencapsulated tetanus toxoid. Vaccine, 1992, 10, 714–20.
15.Freund, J.The mode of action of immunological adjuvants. Advances in Tuberculosis Research, 1956, 7, 130–48.
16.Gilding, D. K.Biodegradable polymers. Biocompatible Clinical Implantable Materials, 1981, 2, 209–32.
17.Gilding, D. K., & Reed, A. M.Biodegradable polymers for use in surgery polyglycolic-poly(lactic acid) homo and copolymers. Polymer, 1979, 11, 711–19.
18.Grant, J. P.The state of the world's children 1992. Oxford, UK. Oxford University Press, 1992.
19.Kohn, J., & Langer, R.Polymerization reactions involving the side chains of a-L-amino acids. Journal of the American Chemical Society, 1987, 109, 817–20.
20.Kohn, J., Niemi, S. M., Albert, E. C., et al. Single-step immunization using a controlled-release, biodegradable polymer with sustained adjuvant activity. Journal ofImmunolog-ical Methods, 1986, 95, 31–38.
21.Langer, R.New methods of drug delivery. Science, 1990, 249, 1527–33.
22.O'Hagan, D. T., Rahman, D., McGee, J. P., et al. Biodegradable microparticles as con-trolled-release antigen delivery systems. Immunology, 1991, 73, 239–42.
23.Preis, I., & Langer, R.A single-step immunization by sustained antigen release. Journal of Immunological Methods, 1979, 28, 193–97.
24.Sanchez, Y., Ionescu-Matin, I., Dreesman, G. R., et al. Humoral and cellular immunity to hepatitis B virus-derived antigen: Comparative activity of Freund's complete adjuvant, alum and liposome. Infection and Immunity, 1980, 30, 728–33.
25.Schneider, A. K.Polylactide sutures. U.S. Patent, 1972, 3, 636–956.
26.Schreier, H., Levy, M., & Milhalko, P.Sustained release of liposome encapsulated genta-mycin and fate of phospholipid following intramuscular injection in mice. Journal of Controlled Release, 1987, 5, 187–92.
27.Singh, M., Singh, A., & Talwar, G. P.Controlled delivery of diphtheria toxoid using biodegradable poly(d.l-lactide) microcapsules. Pharmaceutical Research, 1991, 8, 958–61.
28.Wise, D. L., Fellman, T. D., Sanderson, J. E., et al. Lactic/glycolic acid polymers. In Gregoriadis, G. (ed.), Drug carriers in biology and medicine. London: Academic Press, 1979, 237–70.
